LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway

Table 2 The clinicopathological characteristics of these patients with recurrent HGSC

Patient	FIGO stage	Recurrent site	Recurrence interval (months)	Recurrent lesions obtained for IHC	Method used to obtain specimens	Current status
1	IVB	Brain	10	Pelvic masses	Open-abdominal surgery	DOD
2	IIIB	Pelvic cavity	18	Rectum	Open-abdominal surgery	DOD
3	IIIC	Pelvic/abdominal cavity	29	Transverse colon	Open-abdominal surgery	DOD
4	IIIC	Pelvic cavity	11	Pelvic masses	Open-abdominal surgery	DOD
5	IIIB	Pelvic cavity	45	Pelvic masses	Open-abdominal surgery	DOD
6	IIIC	Pelvic cavity	21	Pelvic masses	Open-abdominal surgery	DOD
7	IIIB	Lymph nodes	18	Inguinal lymph nodes	Biopsy	AWD
8	IIIC	Lymph nodes	20	Supraclavicular lymph nodes	Biopsy	DOD
9	IIA	Pelvic cavity	32	Pelvic masses	Open-abdominal surgery	AWD
10	IVB	Lymph nodes	6	Inguinal lymph nodes	Biopsy	DOD
11	IIIB	Pelvic/abdominal cavity	25	Right colon	Open-abdominal surgery	AWD
12	IIIB	Pelvic/abdominal cavity	47	Transverse colon	Open-abdominal surgery	AWD

HGSC high-grade sercous carcinoma, FIGO International Federation of Gynecology and Obstetrics, IHC immunohistochemistry, DOD die of disease, AWD alive with disease

ISSN: 1475-2867